Literature DB >> 34028634

ASO Author Reflections: Impact of Neoadjuvant Therapy on Survival After Margin-Positive Resection for Pancreatic Cancer.

Asmita Chopra1,2, Joal D Beane3,4.   

Abstract

Entities:  

Year:  2021        PMID： 34028634     DOI： 10.1245/s10434-021-10177-w

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  2 in total

1.  Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.

Authors:  Motokazu Sugimoto; Naoki Takahashi; Michael B Farnell; Thomas C Smyrk; Mark J Truty; David M Nagorney; Rory L Smoot; Suresh T Chari; Rickey E Carter; Michael L Kendrick
Journal:  J Surg Oncol       Date:  2019-08-26       Impact factor: 3.454

2.  Is early-stage pancreatic adenocarcinoma truly early: stage migration on final pathology with surgery-first versus neoadjuvant therapy sequencing.

Authors:  Andrew J Lee; Eve Simoneau; Yi-Ju Chiang; Jeffrey E Lee; Michael P Kim; Thomas A Aloia; Jean-Nicolas Vauthey; Matthew H Katz; Ching-Wei D Tzeng
Journal:  HPB (Oxford)       Date:  2019-02-22       Impact factor: 3.647
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.